These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 12570157)
1. Proteomic analysis at the bedside: early detection of cancer. Petricoin EF; Liotta LA Trends Biotechnol; 2002 Dec; 20(12 Suppl):S30-4. PubMed ID: 12570157 [TBL] [Abstract][Full Text] [Related]
2. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer. Shukla HD; Mahmood J; Vujaskovic Z Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717 [TBL] [Abstract][Full Text] [Related]
3. SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis. Wright GL Expert Rev Mol Diagn; 2002 Nov; 2(6):549-63. PubMed ID: 12465452 [TBL] [Abstract][Full Text] [Related]
4. Clinical proteomics for cancer biomarker discovery and therapeutic targeting. Krieg RC; Paweletz CP; Liotta LA; Petricoin EF Technol Cancer Res Treat; 2002 Aug; 1(4):263-72. PubMed ID: 12625785 [TBL] [Abstract][Full Text] [Related]
5. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy. Fredolini C; Liotta LA; Petricoin EF Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067 [TBL] [Abstract][Full Text] [Related]
6. Clinical proteomics: translating benchside promise into bedside reality. Petricoin EF; Zoon KC; Kohn EC; Barrett JC; Liotta LA Nat Rev Drug Discov; 2002 Sep; 1(9):683-95. PubMed ID: 12209149 [TBL] [Abstract][Full Text] [Related]
7. [Clinical proteomics and new biomarkers in biological fluids]. González-Buitrago JM; Ferreira L; Muñiz MC Med Clin (Barc); 2008 Oct; 131(11):426-34. PubMed ID: 18928725 [TBL] [Abstract][Full Text] [Related]
8. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine. Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327 [TBL] [Abstract][Full Text] [Related]
9. Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer. El Bairi K; Kandhro AH; Gouri A; Mahfoud W; Louanjli N; Saadani B; Afqir S; Amrani M Cell Oncol (Dordr); 2017 Apr; 40(2):105-118. PubMed ID: 27981507 [TBL] [Abstract][Full Text] [Related]
10. Role of proteomics in diagnosis of cancer. Jain KK Technol Cancer Res Treat; 2002 Aug; 1(4):281-6. PubMed ID: 12625787 [TBL] [Abstract][Full Text] [Related]
11. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer. Yang Y; Pospisil P; Iyer LK; Adelstein SJ; Kassis AI PLoS One; 2008; 3(11):e3661. PubMed ID: 18987750 [TBL] [Abstract][Full Text] [Related]
12. Clinical proteomics and biomarker discovery. Johann DJ; McGuigan MD; Patel AR; Tomov S; Ross S; Conrads TP; Veenstra TD; Fishman DA; Whiteley GR; Petricoin EF; Liotta LA Ann N Y Acad Sci; 2004 Jun; 1022():295-305. PubMed ID: 15251975 [TBL] [Abstract][Full Text] [Related]
13. Enzymes and related proteins as cancer biomarkers: a proteomic approach. Liang SL; Chan DW Clin Chim Acta; 2007 May; 381(1):93-7. PubMed ID: 17382922 [TBL] [Abstract][Full Text] [Related]
14. Optomechanical devices for deep plasma cancer proteomics. Kosaka PM; Calleja M; Tamayo J Semin Cancer Biol; 2018 Oct; 52(Pt 1):26-38. PubMed ID: 28867489 [TBL] [Abstract][Full Text] [Related]
15. Proteomics-based anticancer drug discovery and development. Jain KK Technol Cancer Res Treat; 2002 Aug; 1(4):231-6. PubMed ID: 12625781 [TBL] [Abstract][Full Text] [Related]
16. Proteomics in prostate cancer biomarker discovery. Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479 [TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis for the early detection and rational treatment of cancer--realistic hope? Posadas EM; Simpkins F; Liotta LA; MacDonald C; Kohn EC Ann Oncol; 2005 Jan; 16(1):16-22. PubMed ID: 15598930 [TBL] [Abstract][Full Text] [Related]
18. Tissue and plasma proteomics for early stage cancer detection. Peng L; Cantor DI; Huang C; Wang K; Baker MS; Nice EC Mol Omics; 2018 Dec; 14(6):405-423. PubMed ID: 30251724 [TBL] [Abstract][Full Text] [Related]
19. Contribution of oncoproteomics to cancer biomarker discovery. Cho WC Mol Cancer; 2007 Apr; 6():25. PubMed ID: 17407558 [TBL] [Abstract][Full Text] [Related]
20. New cancer biomarkers deriving from NCI early detection research. Verma M; Srivastava S Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]